RESUMO
Ocular allergy is one of the most common disorders of the eye surface. The conventional eye drops lack of therapeutic efficacy due to low ocular bioavailability and decreased drug residence time on eye surface. Hence, the present research work aimed to formulate, optimize, and evaluate the in situ gel for ophthalmic drug delivery. The prepared in situ gel formulations were evaluated for clarity, pH, gelling capacity, viscosity, osmolality, in vitro release study, and kinetic evaluation. ex vivo corneal permeation/penetration study using goat and in vivo studies on rabbits were also performed. Fourier-transformed infrared spectroscopy was also applied to study possible interactions between drug and polymers. The formulations found to be stable, nonirritant, and showed sustained release of the drug for a period of up to 24 hr with no ocular damage. The developed in situ gels loaded with tetrahydrozoline are alternative and promising ocular candidates for the treatment of allergic conjunctivitis.
Assuntos
Agonistas Adrenérgicos/administração & dosagem , Conjuntivite Alérgica/tratamento farmacológico , Imidazóis/administração & dosagem , Descongestionantes Nasais/administração & dosagem , Agonistas Adrenérgicos/química , Animais , Córnea/efeitos dos fármacos , Córnea/metabolismo , Liberação Controlada de Fármacos , Géis , Imidazóis/química , Descongestionantes Nasais/química , CoelhosRESUMO
Clandestine chemists have demonstrated an ability to convert commercially available pseudoephedrine formulations to methamphetamine. Some of these formulations have properties that manufacturers claim limit or block the extraction of pseudoephedrine and its direct conversion to methamphetamine. In this study, 3 commercially available pseudoephedrine formulations were evaluated for ease of extraction and conversion to methamphetamine using a common chemistry technique called the one-pot method that is frequently employed by clandestine chemists. Two marketed pseudoephedrine formulations with claimed tamper-resistant properties - Zephrex-D® and Nexafed® - were compared to Sunmark®, a comparator formulation of pseudoephedrine without tamper-resistant properties. Particle size reduction was conducted using 8 readily available tools; solubility was assessed using 2 common aqueous solutions and various reaction conditions (e.g., temperature, stirring); extractability was evaluated using 8 common organic solvents. The one-pot (single vessel) method commonly used in clandestine processes was employed; chemicals and equipment were purchased locally on the open market. Quantities and addition times of the chemicals used to carry out the procedure and the duration of the reaction were varied to determine the effect on methamphetamine yield. The procedure was appropriately scaled and conducted in a controlled environment to reduce risk and maximize yields. Pseudoephedrine and methamphetamine were quantified using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Standard quantitative procedures were used to determine the quantities of pseudoephedrine and methamphetamine recovered and produced, respectively. Particle size reduction resulted in some loss of material of each pseudoephedrine formulation; Zephrex-D tablets were broken down to a coarse material; Nexafed and Sunmark tablets were reduced to a fine powder. The solubility rates of intact and ground tablets varied by product; Zephrex-D was most resistant to solubilizing while Nexafed and Sunmark were comparable and dissolved completely, demonstrating no solubility-resistant properties. Conditions of the one-pot method were modified throughout the studies to increase methamphetamine yield. Using optimal parameters identified in these studies and allowing the reaction to proceed for 90â¯min, average percent conversions were similar for the 3 formulations: 43.3% for Zephrex-D, 46.4% for Nexafed, and 48.6% for Sunmark. The greatest conversion occurred with a 150â¯min reaction time and resulted in 44.8%-48.4% conversion of Zephrex-D, 54.1%-66.4% conversion of Nexafed, and 58.6%-71.8% conversion of Sunmark. This series of methodological evaluations demonstrated that clandestine chemists can readily produce similar yields of methamphetamine using pseudoephedrine products with and without claimed tamper-resistant technology.
Assuntos
Fracionamento Químico/métodos , Drogas Ilícitas/química , Metanfetamina/química , Descongestionantes Nasais/química , Pseudoefedrina/química , Cromatografia Líquida de Alta Pressão , Estudos de Viabilidade , Metanfetamina/análise , Descongestionantes Nasais/análise , Tamanho da Partícula , Pseudoefedrina/análise , Solubilidade , Solventes/química , Comprimidos , Espectrometria de Massas em TandemAssuntos
Compostos de Benzalcônio/efeitos adversos , Descongestionantes Nasais/química , Mucosa Nasal/efeitos dos fármacos , Conservantes Farmacêuticos/efeitos adversos , Administração Intranasal , Compostos de Benzalcônio/administração & dosagem , Humanos , Descongestionantes Nasais/administração & dosagem , Descongestionantes Nasais/efeitos adversos , Conservantes Farmacêuticos/administração & dosagemRESUMO
The concentration of eleven antibiotics (trimethoprim, oxytetracycline, ciprofloxacin, azithromycin, cefotaxime, doxycycline, sulfamethoxazole, erythromycin, clarithromycin, ofloxacin, norfloxacin), three decongestants (naphazoline, oxymetazoline, xylometazoline) and the antiviral drug oseltamivir's active metabolite, oseltamivir carboxylate (OC), were measured weekly at 21 locations within the River Thames catchment in England during the month of November 2009, the autumnal peak of the influenza A[H1N1]pdm09 pandemic. The aim was to quantify the pharmaceutical response to the pandemic and compare this to drug use during the late pandemic (March 2010) and the inter-pandemic periods (May 2011). A large and small wastewater treatment plant (WWTP) were sampled in November 2009 to understand the differential fate of the analytes in the two WWTPs prior to their entry in the receiving river and to estimate drug users using a wastewater epidemiology approach. Mean hourly OC concentrations in the small and large WWTP's influent were 208 and 350 ng/L (max, 2070 and 550 ng/L, respectively). Erythromycin was the most concentrated antibiotic measured in Benson and Oxford WWTPs influent (max=6,870 and 2,930 ng/L, respectively). Napthazoline and oxymetazoline were the most frequently detected and concentrated decongestant in the Benson WWTP influent (1650 and 67 ng/L) and effluent (696 and 307 ng/L), respectively, but were below detection in the Oxford WWTP. OC was found in 73% of November 2009's weekly river samples (max=193 ng/L), but only in 5% and 0% of the late- and inter-pandemic river samples, respectively. The mean river concentration of each antibiotic during the pandemic largely fell between 17-74 ng/L, with clarithromycin (max=292 ng/L) and erythromycin (max=448 ng/L) yielding the highest single measure. In general, the concentration and frequency of detecting antibiotics in the river increased during the pandemic. OC was uniquely well-suited for the wastewater epidemiology approach owing to its nature as a prodrug, recalcitrance and temporally- and spatially-resolved prescription statistics.
Assuntos
Antibacterianos/química , Antivirais/química , Descongestionantes Nasais/química , Rios , Águas Residuárias/química , Inglaterra , Monitoramento Ambiental , Geografia , Poluentes Químicos da ÁguaRESUMO
BACKGROUND: The personal and societal effects of methamphetamine abuse are well documented. The ease of accessibility to methamphetamine and the quality of the "high" it produces makes the drug highly desired by its abusers. Over time, many methamphetamine users will also become methamphetamine cooks, where pseudoephedrine in over-the-counter cold products is converted to methamphetamine through a simple, albeit extremely dangerous, process. New laws limiting access to these products have had limited success. No existing commercial pseudoephedrine products offer significant impediments to slow or limit the extraction and conversion of pseudoephedrine in clandestine methamphetamine laboratories. OBJECTIVE AND METHODS: A new pseudoephedrine 30 mg tablet product using Impede technology (Nexafed®) to deter methamphetamine production has recently been introduced into the marketplace. Using methods designed to mimic clandestine laboratory processes, the ability of this product to disrupt extraction and conversion of pseudoephedrine to methamphetamine yet provide therapeutic effectiveness was evaluated. RESULTS: Impede™ technology tablets limited the extraction and/or conversion of pseudoephedrine to methamphetamine when compared to a commercially marketed pseudoephedrine product (Sudafed®). Nexafed® tablets were also shown to be bioequivalent to the same control product, thus ensuring therapeutic equivalence. CONCLUSIONS: With the advent of new pseudoephedrine products in the marketplace with features to limit the extraction and conversion of pseudoephedrine to methamphetamine, new tools are now available to minimize the clandestine manufacture of the drug and potentially limit its social impact.
Assuntos
Transtornos Relacionados ao Uso de Anfetaminas/prevenção & controle , Metanfetamina/química , Medicamentos sem Prescrição/administração & dosagem , Pseudoefedrina/administração & dosagem , Transtornos Relacionados ao Uso de Anfetaminas/epidemiologia , Estimulantes do Sistema Nervoso Central/efeitos adversos , Estimulantes do Sistema Nervoso Central/química , Humanos , Drogas Ilícitas/provisão & distribuição , Metanfetamina/efeitos adversos , Descongestionantes Nasais/administração & dosagem , Descongestionantes Nasais/química , Medicamentos sem Prescrição/química , Pseudoefedrina/química , Comprimidos , Tecnologia Farmacêutica/métodosRESUMO
Based on its lower Log P value relative to metoprolol, a marker for the low/high-permeability (P(eff)) class boundary, pseudoephedrine was provisionally classified as BCS low-permeability compound. On the other hand, following oral administration, pseudoephedrine fraction dose absorbed (F(abs)) and systemic bioavailability approaches 100%. This represents a challenge to the generally recognized P(eff)-F(abs) correlation. The purpose of this study was to elucidate the underlying mechanisms behind the confusion in pseudoephedrine's BCS classification. Pseudoephedrine's BCS solubility class was determined, and its physicochemical properties and intestinal permeability were thoroughly investigated, both in vitro and in vivo in rats, considering the complexity of the whole of the small intestine. Pseudoephedrine was found to be unequivocally a high-solubility compound. All of the permeability studies revealed similar phenomenon; at any given intestinal segment/pH, the permeability of metoprolol was higher than that of pseudoephedrine, however, as the intestinal region becomes progressively distal, and the pH gradually increases, pseudoephedrine's permeability rises above that of metoprolol in the former segment. This unique permeability pattern likely explains pseudoephedrine's complete absorption. In conclusion, pseudoephedrine is a BCS Class I compound; no discrepancy between P(eff) and F(abs) is involved in its absorption. Rather, it reflects the complexity behind P(eff) when considering the whole of the intestine. We propose to allow high-permeability classification to drugs with P(eff) that matches/exceeds the low/high class benchmark anywhere throughout the intestinal tract and not restricted necessarily to the jejunum.
Assuntos
Absorção Intestinal , Intestino Delgado/metabolismo , Descongestionantes Nasais/metabolismo , Pseudoefedrina/metabolismo , Administração Oral , Animais , Soluções Tampão , Concentração de Íons de Hidrogênio , Masculino , Membranas Artificiais , Metoprolol/metabolismo , Descongestionantes Nasais/administração & dosagem , Descongestionantes Nasais/química , Descongestionantes Nasais/classificação , Octanóis/química , Permeabilidade , Pseudoefedrina/administração & dosagem , Pseudoefedrina/química , Pseudoefedrina/classificação , Ratos , Ratos Wistar , SolubilidadeRESUMO
The fluorescence and ultraviolet spectroscopy were explored to study the interaction between Oxymetazoline hydrochloride (OMZH) and mucin under imitated physiological condition. The results demonstrated that the fluorescence quenching mechanism between OMZH and mucin is a combined quenching process. The binding constants (K(a)), binding sites (n) and the corresponding thermodynamic parameters (ΔG, ΔH, and ΔS) of the interaction system were calculated at different temperatures. The hydrogen bonds and van der Waals forces play a major role in the interaction between OMZH and mucin. According to Förster non-radiation energy transfer theory, the binding distance between OMZH and mucin was calculated.
Assuntos
Agonistas alfa-Adrenérgicos/metabolismo , Mucinas/metabolismo , Descongestionantes Nasais/metabolismo , Oximetazolina/metabolismo , Agonistas alfa-Adrenérgicos/química , Sítios de Ligação , Mucinas/química , Descongestionantes Nasais/química , Oximetazolina/química , Ligação Proteica , Espectrometria de Fluorescência , Espectrofotometria Ultravioleta , TermodinâmicaRESUMO
AIM: This study aimed to investigate the in vitro effects of three paediatric liquid oral medicines on bovine dental enamel subsurfaces under pH cycling conditions. METHODS: Bovine enamel blocks were evaluated for surface hardness at baseline for sample selection. 52 intact bovine enamel blocks (16mm(2)) were randomly divided into four groups (n=13) according to the immersion treatments: G1: antibiotic (Klaricid®), G2: antihistamine (Claritin®), G3: antihistamine (Dimetapp®) and G4: control (de-ionised water). The blocks were submitted to pH cycling treatments twice a day for 12 days. The medicines were evaluated for pH, viscosity, and concentration of calcium, phosphate and fluoride. After the treatment period, cross-sectional microhardness (CSMH) measurements of the enamel blocks were taken and the data, expressed in Knoop hardness number (kg/mm(2)) was used to calculate the ΔS. STATISTICS: ANOVA followed by the Tukey test were used for statistical analyses (p<0.05). RESULTS: The antibiotic Klaricid® showed the highest concentration of fluoride, calcium and phosphate. Considering pH and viscosity, the following pattern was observed according to the treatment group: G4>G1>G2>G3 and G1>G2>G3>G4 respectively. Regarding the demineralisation pattern, the following results were observed: G4>G3>G2>G1. Compared to the control, the antibiotic and both the antihistamines provoked less demineralisation of the enamel blocks (p<0.05). CONCLUSIONS: Antibiotic G1 (Klaricid®) presented an in vitro protective effect against acid attacks probably due to its mineral content and viscosity.
Assuntos
Esmalte Dentário/efeitos dos fármacos , Excipientes Farmacêuticos/efeitos adversos , Anatomia Transversal , Animais , Antibacterianos/efeitos adversos , Antibacterianos/química , Bromofeniramina/efeitos adversos , Bromofeniramina/química , Cálcio/análise , Bovinos , Claritromicina/efeitos adversos , Claritromicina/química , Solubilidade do Esmalte Dentário/efeitos dos fármacos , Combinação de Medicamentos , Fluoretos/análise , Dureza , Antagonistas não Sedativos dos Receptores H1 da Histamina/efeitos adversos , Antagonistas não Sedativos dos Receptores H1 da Histamina/química , Concentração de Íons de Hidrogênio , Loratadina/efeitos adversos , Loratadina/química , Descongestionantes Nasais/efeitos adversos , Descongestionantes Nasais/química , Excipientes Farmacêuticos/química , Fosfatos/análise , Pseudoefedrina/efeitos adversos , Pseudoefedrina/química , Distribuição Aleatória , Soluções , Desmineralização do Dente/induzido quimicamente , ViscosidadeRESUMO
In urine drug testing, enantiomer analysis is used to determine whether a positive methamphetamine result could be due to use of an over-the-counter (OTC) nasal inhaler containing L-methamphetamine. D-methamphetamine at more than 20% of the total is considered indicative of a source other than an OTC product. This interpretation is based on a 1991 Department of Health and Human Services (HHS) Technical Advisory. We performed studies to verify the methamphetamine enantiomer content of current OTC nasal inhalers and to evaluate current laboratory testing capabilities. This study demonstrated that OTC inhalers contain less than 1% D-methamphetamine. A proficiency testing (PT) set for HHS-certified laboratories performing methamphetamine enantiomer testing found D-methamphetamine percentages that were consistently 1 to 3% higher than theoretical due to optical impurity of the derivatizing reagent N-trifluoroacetyl-L-prolyl chloride (L-TPC). The PT results also demonstrate that laboratories can accurately determine 20% D-methamphetamine in samples with total methamphetamine concentrations down to 250 ng/mL. Based on these studies, the guideline of >20% D-methamphetamine is appropriate for interpreting results obtained using current laboratory methods.
Assuntos
Estimulantes do Sistema Nervoso Central/urina , Guias como Assunto , Metanfetamina/urina , Detecção do Abuso de Substâncias , Administração por Inalação , Estimulantes do Sistema Nervoso Central/administração & dosagem , Estimulantes do Sistema Nervoso Central/química , Estimulantes do Sistema Nervoso Central/farmacocinética , Contaminação de Medicamentos , Controle de Medicamentos e Entorpecentes/métodos , Humanos , Imunoensaio , Indicadores e Reagentes/química , Ensaio de Proficiência Laboratorial , Limite de Detecção , Metanfetamina/administração & dosagem , Metanfetamina/química , Metanfetamina/farmacocinética , Descongestionantes Nasais/administração & dosagem , Descongestionantes Nasais/química , Descongestionantes Nasais/farmacocinética , Descongestionantes Nasais/urina , Medicamentos sem Prescrição/administração & dosagem , Medicamentos sem Prescrição/análise , Medicamentos sem Prescrição/química , Medicamentos sem Prescrição/farmacocinética , Prolina/análogos & derivados , Prolina/química , Estereoisomerismo , Detecção do Abuso de Substâncias/normas , Estados Unidos , United States Dept. of Health and Human Services , United States Substance Abuse and Mental Health Services AdministrationRESUMO
AIMS: To assess the effectiveness of methamphetamine precursor regulations in reducing illicit methamphetamine supply and use. METHODS: A systematic review of 12 databases was used to identify studies that had evaluated the impact of methamphetamine precursor regulations on methamphetamine supply and/or use. The guidelines of the Effective Practice and Organization of Care Group (EPOC) of The Cochrane Collaboration were used to determine which study designs were included and assess their quality. RESULTS: Ten studies met the inclusion criteria. These studies evaluated 15 interventions (13 regulations and two related interdiction efforts), all of which were located in North America. Interventions had consistent impacts across various indicators of methamphetamine supply and use. Seven of the 15 interventions produced reductions in methamphetamine indicators (ranging from 12% to 77%). Two of the largest impacts were seen following interdiction efforts, involving the closure of rogue pharmaceutical companies. There was no evidence of a shift into other types of drug use, or injecting use, although the impact on the synthetic drug market was not examined. Null effects were related largely to the existence of alternative sources of precursor chemicals or the availability of imported methamphetamine. CONCLUSIONS: Methamphetamine precursor regulations can reduce indicators of methamphetamine supply and use. Further research is needed to determine whether regulations can be effective outside North America, particularly in developing countries, and what impact they have on the broader synthetic drug market. Improved data on precursor diversion are needed to facilitate the evaluation of precursor regulations.
Assuntos
Transtornos Relacionados ao Uso de Anfetaminas/prevenção & controle , Estimulantes do Sistema Nervoso Central/química , Drogas Desenhadas/química , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Drogas Ilícitas/legislação & jurisprudência , Metanfetamina/química , Pró-Fármacos/química , Estimulantes do Sistema Nervoso Central/metabolismo , Comércio/legislação & jurisprudência , Drogas Desenhadas/metabolismo , Países em Desenvolvimento , Humanos , Drogas Ilícitas/química , Drogas Ilícitas/metabolismo , Aplicação da Lei/métodos , Metanfetamina/metabolismo , Descongestionantes Nasais/química , Descongestionantes Nasais/metabolismo , América do Norte , Pró-Fármacos/metabolismo , Avaliação de Programas e Projetos de Saúde , Pseudoefedrina/química , Pseudoefedrina/metabolismoRESUMO
A liquid chromatographic method was applied for the analysis of two sustained-release mixtures containing dextromethorphane hydrobromide, carbinoxamine maleate with either phenylephrine hydrochloride in pharmaceutical capsules (Mix 1) or phenyl-propanolamine, methylparaben, and propylparaben, which bonds as a drug base to ion exchange resin in pharmaceutical syrup (Mix 2). The method was used for their simultaneous determination using a CN column with a mobile phase consisting of acetonitrile-12 mM ammonium acetate in the ratio of 60:40 (v/v, pH 6.0) for Mix 1 and 45:55 (v/v, pH 6.0) for Mix 2.
Assuntos
Antitussígenos/análise , Cromatografia por Troca Iônica/métodos , Dextrometorfano/análise , Descongestionantes Nasais/análise , Fenilefrina/análise , Piridinas/análise , Antitussígenos/química , Cápsulas/química , Preparações de Ação Retardada , Dextrometorfano/química , Estabilidade de Medicamentos , Análise dos Mínimos Quadrados , Descongestionantes Nasais/química , Parabenos/análise , Parabenos/química , Fenilefrina/química , Fenilpropanolamina/análise , Fenilpropanolamina/química , Piridinas/química , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
The influence of the ageing process on the low frequency behavior of some electrical parameters of naphazoline hydrochloride solutions at 0.5% and 1% in concentration and of 2% paracetamol syrup, is studied. The impedance measurements were performed, in the range between 200 Hz and 1 MHz, using an impedance analyzer and a cell for liquids with plane parallel electrodes whose separation can be changed by using a set of spacers, provided by the manufacturer, in order to get better control of the influence of electrodes polarization effect. The ageing state was artificially generated by dilution and/or heating separated procedures. The results show that this dielectric technique can be used as a good quality complementary control technique.
Assuntos
Acetaminofen/química , Analgésicos não Narcóticos/química , Nafazolina/química , Descongestionantes Nasais/química , Acetaminofen/administração & dosagem , Administração Intranasal , Algoritmos , Analgésicos não Narcóticos/administração & dosagem , Combinação de Medicamentos , Impedância Elétrica , Eletrodos , Nafazolina/administração & dosagem , Descongestionantes Nasais/administração & dosagem , Soluções Farmacêuticas , SuspensõesAssuntos
Antitussígenos/química , Citrus/química , Dextrometorfano/química , Drogas Ilícitas/química , Transtornos Relacionados ao Uso de Substâncias , Acetaminofen/química , Analgésicos não Narcóticos/química , Antitussígenos/administração & dosagem , Cristalização , Dextrometorfano/administração & dosagem , Doxilamina/química , Combinação de Medicamentos , Cromatografia Gasosa-Espectrometria de Massas , Antagonistas dos Receptores H2 da Histamina/química , Descongestionantes Nasais/química , Medicamentos sem Prescrição , Pseudoefedrina/química , SoluçõesRESUMO
We developed and optimized a novel pseudoephedrine hydrochloride (PSE) sustained-release dosage form. The system comprises immediate-release mini-tablets (IRMT) and sustained-release mini-tablets (SRMT) contained in a hydroxypropyl methylcellulose (HPMC) capsule. The IRMT contained PSE, excipients and low-substituted hydroxypropyl cellulose (a disintegrant), and the tablets were coated with HPMC, a water-soluble polymer. IRMT prepared with varying amounts of low-substituted hydroxypropyl cellulose all dissolved completely within the first 60min, so low-substituted hydroxypropyl cellulose content does not greatly influence PSE release. The SRMT contained only PSE and excipients, and were coated with a mixture of HPMC and the water-insoluble polymer ethylcellulose. The PSE release profile for the SRMT could be controlled by varying the thickness of the coat, and the lag time could be controlled by varying the amount of ethylcellulose present in the polymer coat. PSE was released immediately from our encapsulated mini-tablet system and release was sustained over an extended period of time: the PSE in the IRMT dissolved within 60min, whereas the PSE in the SRMT was released over 8-10h. This system can be modified to yield various extended drug-release profiles, thereby harnessing the benefits of both SRMT and IRMT.
Assuntos
Excipientes/química , Metilcelulose/análogos & derivados , Descongestionantes Nasais/química , Pseudoefedrina/química , Cápsulas , Celulose/análogos & derivados , Celulose/química , Química Farmacêutica , Preparações de Ação Retardada , Derivados da Hipromelose , Metilcelulose/química , Solubilidade , Comprimidos , Fatores de TempoRESUMO
An alternative method for the determination of fexofenadine (FEX) and pseudoephedrine (PSE) in their combined tablet formulation has been developed, employing the partial least squares (PLS) analysis of spectral data of the analytes in their pharmaceutical association. A full-factorially designed set of 16 synthetic samples was employed for calibration purposes. The calibration models were constructed with wavelengths selection, in the ultraviolet region, according to their predictive ability. These were validated internally by the leave-one-out procedure and externally, employing appropriate sets of validation samples. The described method was linear for both analytes, over the range 160.6-301.2 mg L(-1) for FEX (R(2)=0.9993) and between 325.6 and 610.5 mg L(-1) for PSE (R(2)=0.9992). It was accurate, exhibiting 99.8% and 99.9% drug recoveries for FEX and PSE, respectively (N=9), while in the intermediate precision experiment relative standard deviations were 1.4% for FEX and 1.2% for PSE. The contents of both analytes were assayed in commercial tablets employing this method and the results were compared with those furnished by HPLC, being in good statistical agreement. The method represents an improvement over the first derivative of spectral ratio (DSR) technique and allows high sample throughput with minimum reagent consumption and waste generation. The obtained results confirm that the method is highly suitable for its intended purpose.
Assuntos
Antagonistas não Sedativos dos Receptores H1 da Histamina/análise , Descongestionantes Nasais/análise , Pseudoefedrina/análise , Terfenadina/análogos & derivados , Calibragem , Cromatografia Líquida de Alta Pressão/métodos , Combinação de Medicamentos , Antagonistas não Sedativos dos Receptores H1 da Histamina/química , Análise dos Mínimos Quadrados , Estrutura Molecular , Descongestionantes Nasais/química , Pseudoefedrina/química , Reprodutibilidade dos Testes , Espectrofotometria Ultravioleta , Comprimidos/análise , Comprimidos/química , Terfenadina/análise , Terfenadina/química , Fatores de TempoRESUMO
Some over-the-counter (OTC) cold and allergy medicines are being moved behind the counter at pharmacies nationwide as part of the fight against illegal drug production.
Assuntos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Efedrina/provisão & distribuição , Metanfetamina/síntese química , Medicamentos sem Prescrição/provisão & distribuição , Controle de Medicamentos e Entorpecentes/métodos , Humanos , Descongestionantes Nasais/química , Descongestionantes Nasais/provisão & distribuiçãoRESUMO
The performance of five reversed-phase columns which included a standard C18 phase, a polar embedded phase (amide group), a polyethyleneglycol phase, a cyano phase, and a perfluorinated phase, all coming from the same manufacturer, have been studied. They were systematically compared with a test mixture containing basic, neutral and acidic compounds of very different polarities, as well as different functional groups (acetaminophen, phenylephrine hydrochloride or phenylpropanolamine hydrochloride, chlorpheniramine maleate, 4-aminophenol, 4-chloracetanilide and 4-nitrophenol) at three pH levels (2.5, 4.6 and 7.0) and three proportions of buffer/acetonitrile (80:20, 50:50 and 20:80, v/v). The results obtained have permitted our group to develop unique applications with these columns, as these compounds are not only a test mixture, due to their chemical characteristics, but they are also usually contained in pharmaceutical formulations for the relief of common cold symptoms and have been selected as a real-life case study. Moreover, after observing the reversed-phase and normal-phase-like characteristics for certain analytes on the perfluorinated phase, a systematic study was developed in this column to understand the chromatographic behaviour of these compounds at three pH (2.5, 4.6 and 7.0) and seven different organic proportions from 20 to 80% acetonitrile. The predominant electrostatic interactions observed on the perfluorinated phase could explain its special behaviour and the high retention at higher percentages of organic solvent, especially for amine compounds, which makes this column very advantageous in working with LC/MS. Different applications with volatile buffers, such as TFA at pH 2.5 and ammonium acetate at pH 4.6 and 7.0, were also considered. Some results have been related to parameters frequently employed for column description.
Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Fluorocarbonos , Preparações Farmacêuticas/química , Acetaminofen/análise , Acetaminofen/química , Acetonitrilas/química , Amidas , Analgésicos não Narcóticos/análise , Analgésicos não Narcóticos/química , Clorfeniramina/análise , Clorfeniramina/química , Antagonistas dos Receptores Histamínicos H1/análise , Antagonistas dos Receptores Histamínicos H1/química , Concentração de Íons de Hidrogênio , Descongestionantes Nasais/análise , Descongestionantes Nasais/química , Preparações Farmacêuticas/análise , Fenilefrina/análise , Fenilefrina/química , PolietilenoglicóisRESUMO
The purpose of this study was the preparation and characterization of sponge-like, in situ gelling inserts based on bioadhesive polymers. Hydrophilic polymers (carrageenan, Carbopol, chitosan, hydroxypropyl methylcellulose (HPMC) K15M and E5, sodium alginate, sodium carboxy methylcellulose (NaCMC), polyvinyl pyrrolidone (PVP) 90, xanthan gum) were dissolved with/without the model drug oxymetazoline HCl in demineralized water and lyophilized into small inserts. The drug release, water uptake, mechanical properties, X-ray diffraction and bioadhesion potential of the nasal inserts were investigated. A sponge-like structure of nasal inserts was formed with amorphous, but not with crystalline polymers during the freeze-drying process. The insert hardness increased with the glass transition temperature of the polymer (PVP25Assuntos
Preparações de Ação Retardada/química
, Géis/química
, Cavidade Nasal
, Polímeros/química
, Adesividade
, Carboximetilcelulose Sódica/química
, Carragenina/química
, Liofilização
, Dureza
, Descongestionantes Nasais/química
, Oximetazolina/química
, Polissacarídeos Bacterianos/química
, Propriedades de Superfície
, Água/química
Assuntos
Efedrina/química , Descongestionantes Nasais/química , Medicamentos sem Prescrição/química , Fenilefrina/química , Vasos Sanguíneos/efeitos dos fármacos , Resfriado Comum/tratamento farmacológico , Controle de Medicamentos e Entorpecentes , Efedrina/uso terapêutico , Humanos , Metanfetamina/síntese química , Descongestionantes Nasais/uso terapêutico , Fenilefrina/uso terapêuticoRESUMO
Two potential oxidation degradants of oxymetazoline have been isolated by liquid chromatography and monitored by electrospray single quadrupole mass spectrometry. The structures of the products are shown to be oxymetazoline N-oxide and hydroxyamine by multiple-stage fragmentation ion trap mass spectrometry. The product ion spectra were installed in a library database and the library was used to examine an aged commercial product; one of the degradants was detected, but at a level of less than 0.1% of the parent.